Chemotherapy of leprosy for control programmes : report of a WHO study group [meeting held in Geneva from 12 to 16 October 1981]
Material type:
TextSeries: World Health Organization technical report series ; no. 675Publication details: Geneva : World Health Organization, 1982.Description: 33 pISBN: - 9241206756
- QV 259
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Books
|
WHO HQ READING-RM | HQ SERIAL (Browse shelf(Opens below)) | 1 | Available | 00009284 | ||
|
Books
|
WHO HQ BORROWABLE-COLL-STACKS | QV 259 82WH (Browse shelf(Opens below)) | 2 | Withdrawn | 00009285 | ||
|
Books
|
WHO HQ ONLINE-IRIS | QV 259 82WH (Browse shelf(Opens below)) | 3 | Available | O9241206756 | ||
|
Books
|
WHO HQ READING-RM | QV 259 82WH ARA (Browse shelf(Opens below)) | 1 | Available | 00027315 | ||
|
Books
|
WHO HQ ONLINE-IRIS | QV 259 82WH ARA (Browse shelf(Opens below)) | 2 | Available | O9241206756ARA | ||
|
Books
|
WHO HQ ONLINE-IRIS | HQ SERIAL RUS (Browse shelf(Opens below)) | 1 | Available | O9241206756RUS |
Browsing WHO HQ shelves, Shelving location: ONLINE-IRIS Close shelf browser (Hides shelf browser)
| QV 256 2011ME Methods and techniques for assessing exposure to antimalarial drugs in clinical field studies. | QV 256 98IN Interventions to improve antimalarial use / | QV 259 82WH Chemotherapy of leprosy for control programmes : | QV 259 82WH ARA Chemotherapy of leprosy for control programmes : | QV 259 82WH-1 Chimiothérapie pour les programmes de lutte antilépreuse : | QV 259 82WH-2 Quimioterapia de la lepra para los programas de lucha : | QV 268 91WH WHO model prescribing information : |
Issued in Portuguese as: Publicação científica / Organização Pan-Americana da Saúde ; no. 465.
Russian version of nos. 658-678 bound together (barcode no. 00073789).
Proposes globally applicable regimens to treat the different groups of multibacillary patients and a further combined regimen designed for the short-term chemotherapy of paucibacillary patients. The report also recommends ways of overcoming the operational problems created by the move from dapsone monotherapy to the complexities of multidrug therapy.
ara eng fre por rus spa.
WHO monograph
4
There are no comments on this title.